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Transcriptome analysis of 
developing lens reveals abundance 
of novel transcripts and extensive 
splicing alterations
Rajneesh Srivastava1, Gungor Budak1, Soma Dash2, Salil A. Lachke2,3 & Sarath Chandra 
Janga1,4,5
Lens development involves a complex and highly orchestrated regulatory program. Here, we 
investigate the transcriptomic alterations and splicing events during mouse lens formation using RNA-
seq data from multiple developmental stages, and construct a molecular portrait of known and novel 
transcripts. We show that the extent of novelty of expressed transcripts decreases significantly in 
post-natal lens compared to embryonic stages. Characterization of novel transcripts into partially novel 
transcripts (PNTs) and completely novel transcripts (CNTs) (novelty score ≥ 70%) revealed that the PNTs 
are both highly conserved across vertebrates and highly expressed across multiple stages. Functional 
analysis of PNTs revealed their widespread role in lens developmental processes while hundreds of CNTs 
were found to be widely expressed and predicted to encode for proteins. We verified the expression of 
four CNTs across stages. Examination of splice isoforms revealed skipped exon and retained intron to be 
the most abundant alternative splicing events during lens development. We validated by RT-PCR and 
Sanger sequencing, the predicted splice isoforms of several genes Banf1, Cdk4, Cryaa, Eif4g2, Pax6, and 
Rbm5. Finally, we present a splicing browser Eye Splicer (http://www.iupui.edu/~sysbio/eye-splicer/), to 
facilitate exploration of developmentally altered splicing events and to improve understanding of post-
transcriptional regulatory networks during mouse lens development.
The past decade has seen a surge in transcriptome-level studies for specific developmental stages of the eye and its 
tissue sub-types1, 2. The development of the eye involves a complex and highly orchestrated regulatory program 
with several specification and differentiation processes3, 4. The lens is a transparent tissue that focuses light on the 
retina5. It originates from the surface ectoderm early in embryogenesis and is composed of two cell types, namely 
the anteriorly located epithelial cells and the posteriorly located fiber cells6, 7. During development and through-
out the life of the animal, epithelial cells differentiate into fiber cells that elongate and migrate towards the center 
of the lens, while degrading their organelles, including nucleus.
High-throughput sequencing techniques, collectively known as Next Generation Sequencing (NGS) 
approaches, have significantly advanced our understanding of the molecular portrait of various cell types and dis-
ease states8–10. One of the primary advantages of high-throughput RNA sequencing (RNA-Seq) is that it enables 
accurate assembly of the transcriptome, and its alterations across experimental conditions, so as to allow prioriti-
zation of the transcripts and splice forms that are potentially most relevant to the observed phenotype. However, 
employing RNA-Seq datasets for genome-scale elucidation of the splicing alterations across developmental11 and 
disease states12 or to study inter-individual differences in humans is still in its early stages13.
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Greater than 94% of multi-exonic genes in the human genome are alternatively spliced14. Further, alternative 
splicing is an essential and highly controlled post-transcriptional regulatory mechanism which provides tran-
scriptomic and proteomic diversity in eukaryotic organisms15. Due to the extensive prevalence of splicing events 
in higher eukaryotes, various transcriptomic datasets across developmental stages have been previously explored 
in multiple model organisms to study the structure and composition of protein-coding and non-coding genes16–19. 
These RNA-Seq based studies revealed more accurate and comprehensive set of known and novel genes for down-
stream functional and comparative analysis.
Previous studies report that ocular tissues such as the retina can exhibit highly diverse transcript profiles with 
hundreds of novel transcripts, likely contributed by the ensemble of multiple cell types abundant in retina1, 20. 
However, few RNA-Seq based studies have been conducted so far for investigating the lens transcriptome21, 22 
especially over different developmental stages23, 24. Further, these studies have used only known or annotated 
genes in their analysis. Thus, to date the complete lens transcriptome and the various isoforms expressed in the 
developing lens has not been fully characterized. In this study, we investigated the transcriptomic alterations and 
splicing events from publicly available lens RNA-Seq data, and have constructed a comprehensive molecular por-
trait of known as well as novel transcript isoforms in the mouse lens across developmental stages.
Results
Although mouse lens transcriptome profiling has been the focus of few studies in recent years21–24, our under-
standing of the complete repertoire of expressed transcripts and their splicing alterations during lens develop-
ment is far from complete. In this study, we investigated the transcriptomic alterations and alternative splicing 
events in mouse lens across developmental stages. Overview of the analysis pipeline is illustrated in Fig. 1. In 
brief, we collected the available RNA-Seq data for mouse lens across varying developmental stages and processed 
the raw sequence reads using HISAT25 and StringTie26. The processed and quantified data were formatted into 
Figure 1. (a) Overview of the transcriptome analysis across developmental stages in mouse lens. 
Transcriptomes of mouse lens spanning seven developmental stages (three embryonic; E15, E15.5, E18 and 
four postnatal; P0, P3, P6, P9 stages with biological replicates) were collected from published sources for our 
study. Curated RNA sequence data was quality filtered using FASTX toolkit. High quality raw sequence reads 
were processed and aligned to mouse reference genome mm10 using HISAT and output collected as SAM files. 
Post processing (i.e. conversion of SAM to sorted BAM) of aligned reads was accomplished using SAMTools. 
Aligned and post processed RNA-Seq bam files associated with each developmental stage were utilized for two 
purposes. Firstly, for identifying and quantifying the expression levels of known and novel transcripts across 
seven developmental stages using StringTie, followed by an evolutionary and functional analysis to uncover 
high confident completely novel transcripts in developing lens. Secondly, the processed bam files were also 
employed for the identification of alternative splicing events using rMATS (replicate Multivariate Analysis of 
Transcript Splicing)27 followed by functional analysis of genes belonging to the enriched splice events. Finally, 
the results of the most prominent splicing events namely skipped exon and retained intron events are also made 
available through Eye splicer, a web based splicing browser showing developmentally altered splicing events in 
mouse lens.
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expression matrices and were utilized for investigation of complete transcriptomic architecture, extent of tran-
script novelty, and their evolutionary conservation (see Materials and Methods). Additionally, we investigated 
the alternative splicing events using rMATS27 followed by an extensive functional analysis of the genes associated 
with enriched splicing event types. The most prominent splicing event types namely skipped exon and retained 
intron events were made available through Eye splicer (http://www.iupui.edu/~sysbio/eye-splicer/), a web based 
splicing browser showing developmentally altered splicing events in mouse lens.
Overview of the dataset and construction of the developmental transcriptomes in lens. We 
collected the RNA sequencing data from two studies23, 28 and preprocessed them using a NGS pipeline for data 
processing to facilitate their downstream analysis (See Materials and Methods, Fig. 1 and Table 1). The RNA-Seq 
data of different developmental stages were processed separately using the proposed pipeline. Raw RNA-Seq reads 
were aligned onto mouse reference genome mm10 using HISAT. The overall percentage of alignment for each 
sample is shown in Table 1. All datasets exhibited a good read quality (Phred score > 20) and a high fraction of 
read alignment to the reference genome (alignment score ≥ 93%) using HISAT.
Since previous reports studying the eye transcriptomes indicated diverse transcriptomic architecture4, our goal was 
to investigate whether such diversity exists in different developmental stages of lens. For this purpose we first quantified 
the expression of transcripts and corresponding exons using StringTie. This allowed us to obtain expression levels for 
90689 transcripts (68166 annotated and 22523 novel transcripts) in the mouse genome. The analysis indicated the 
existence of ~25% novel transcripts in the developmental mouse lens transcriptome. In order to further investigate the 
extent of the novel transcripts in each developmental stage, we analyzed the proportion of known and novel transcripts 
(with TPM > 1.0) across different developmental stages (Fig. 2a). We observed that in each of the developmental stages 
of mouse lens there are about ~35–50% of novel transcripts. Such variations in the distribution of known versus novel 
transcripts with respect to different developmental stages was found to be consistent despite filtering for different TPM 
thresholds (i.e. >0.5, >2.0, and >5.0). In particular, despite the expression threshold employed for defining the expres-
sion of a transcript, several thousands of novel transcripts were still identified (Figure S1a–c and Table S1). These obser-
vations support the presence of a diverse transcriptome with thousands of novel transcripts being expressed in various 
lens developmental stages as well as the predominance of complex transcriptional and post-transcriptional regulatory 
mechanisms in embryonic and post-natal stages during mouse lens formation.
Embryonic stages exhibit the highest extent of novelty for the newly discovered transcripts 
with a significant decrease in post-natal stages. To further investigate whether the expression of these 
novel transcripts differs between stages, we calculated novelty score of a transcript to measure the differences in 
the extent of novelty across stages using KS (Kolmogorov–Smirnov) test. Novelty score of a transcript is defined as 
the percentage of non-overlapping novel transcript length to the reference annotated transcriptome (Fig. 2b). We 
observed that in embryonic stages, each pair of neighboring developmental stages were found to be significantly 
different in their distribution of novelty scores for the novel transcripts (p-value ≤ 0.005) and this pattern was 
observed until birth (P0). In general, the novelty score distributions of the novel transcripts for embryonic stages 
were observed to be significantly higher compared to those seen in post-natal stages (median novelty score: 10.89 
vs 9.04, p = 1.06e-12, KS-test, Fig. 2b).
Significant fraction of the partially novel transcripts in lens were found to be highly conserved 
across vertebrates and associated with neural system development, structural morphogene-
sis, protein localization, cell division and differentiation processes. In our study, we identified a 
total of 22523 novel transcripts (~25% of total transcripts) in mouse lens as documented in Table S2 along with 







1 SRR2039769 E15 26225632 PE 100 13772390 2754478000 94
2 SRR2039770 E15 26225632 PE 100 13542500 2708500000 95
3 SRR953395 E15.5 24161570 SE 52 48552190 2524713880 94
4 SRR953394 E15.5 24161570 SE 52 47574424 2473870048 94
5 SRR953393 E15.5 24161570 SE 52 42525381 2211319812 94
6 SRR2039771 E18 26225632 PE 100 17810970 3562194000 93
7 SRR2039772 E18 26225632 PE 100 18019388 3603877600 93
8 SRR2039773 P0 26225632 PE 100 17766309 3553261800 93
9 SRR2039774 P0 26225632 PE 100 14533000 2906600000 93
10 SRR2039775 P3 26225632 PE 100 15495833 3099166600 93
11 SRR2039776 P3 26225632 PE 100 13072393 2614478600 93
12 SRR2039777 P6 26225632 PE 100 16965754 3393150800 93
13 SRR2039778 P6 26225632 PE 100 17658286 3531657200 93
14 SRR2039779 P9 26225632 PE 100 18874309 3774861800 93
15 SRR2039780 P9 26225632 PE 100 13563853 2712770600 93
Table 1. Metadata associated with the collected RNA-seq samples across lens developmental stages and results 
of their alignment with mouse mm10 reference genome from Ensembl.
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their novelty score and expression levels. As discussed above, we observed differences in the distribution of nov-
elty scores of transcripts between embryonic and postnatal developmental stages. Hence, we further classified 
the novel transcripts based on their novelty score (See Materials and Methods and Table S2). We categorized the 
novel transcripts into two groups; Partially Novel Transcripts (PNTs, novelty score < 70%, 13207 transcripts) and 
Completely Novel Transcripts (CNTs, novelty score ≥ 70%, 9316 transcripts).
To investigate and compare the extent of conservation of known and novel transcripts, we used phastCons 
scores from UCSC Genome Browser, which provide a nucleotide level conservation score across 46 vertebrate 
genomes, facilitating a measure to quantify conservation for mouse genomic loci (see Materials and Methods). 
We calculated the phastCons score distributions for each group of transcripts; known transcripts, PNTs and CNTs 
(Materials and Methods section, Fig. 2c). We observed a significant difference in phastCons score distributions 
among these groups (median for known transcripts = 0.67, median for PNTs = 0.76, and median for CNTs = 0.13; 
Wilcoxon rank sum test, p-value < 2.2e-16). The score distribution indicates that PNTs exhibit higher conserva-
tion patterns than already known transcripts while their patterns were less comparable to CNTs. These observa-
tions suggest that since lens tissue and corresponding cell line transcriptomes have been poorly or rarely studied 
by genome annotation consortiums like ENCODE29 or FANTOM30, it is possible that hundreds of transcripts 
specific to lens may have been rarely documented in genomic/transcriptomic resources. However, integrative 
Figure 2. (a) Histogram showing the proportion of known and novel transcripts identified across 
various lens developmental stages in mouse. Only transcripts exhibiting an expression higher than 1 
TPM (Transcripts Per Million reads sequenced) are considered in this plot. However, the proportions of 
known versus novel remained stable irrespective of the threshold on the expression level of a transcript 
(Figure S1). (b) Violin plot showing the distributions of novelty scores of identified transcripts, expressed in 
embryonic and postnatal stages. Violin plot represents the boxplot combined with kernel density showing 
the distribution pattern of a data vector. Novelty score of the transcripts expressed (with TPM > 5.0) at least 
in one stage were employed to generate two violin plots corresponding to the embryonic (E15, E15.5, E18) 
and postnatal (P0, P3, P6, P9) stages respectively. Differences in the distribution of novelty scores between 
embryonic and post-natal stages were compared using Kolmogorov–Smirnov test. Median novelty score 
for E and P were 10.89 and 9.043 respectively. (c) This panel shows the distribution of PhastCons scores, 
reflecting the extent of conservation for known, partially novel (novelty score < 70%) and completely novel 
(novelty score ≥ 70%) transcripts identified across developmental stages in lens. The phastCons score (PS) 
provides nucleotide level conservation of mouse genomic loci across 46 vertebrate genomes. We found 
each pair of these transcript classes to be significantly different in their extent of conservation (p < 2.2e-16, 
Wilcoxon rank sum test) with median conservation scores 0.67, 0.76, and 0.13 for known, partially novel and 
completely novel transcript groups respectively. (d) Gene ontology enrichment based functional grouping 
using annotations for genes corresponding to the high confidence partially novel transcripts (PS > 0.76). 
Functional grouping of the GO-terms based on GO hierarchy was represented as clustered GO-network 
using the Cytoscape67-ClueGO31 plugin. Significant clustering (p < 1e-10) of genes (color coded by functional 
annotation group they belong to) based on enriched GO-biological processes generated by ClueGO analysis, 
with size of the nodes indicating the level of significant association of genes per GO-term, were shown. Only 
selected biological processes and associated networks are shown in this figure panel, while Fig. S2 shows the 
complete set of functional groups identified from this analysis.
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analyses and databases based on next generation RNA-sequencing datasets specific to such overlooked tissues, 
would be able to capture such missing transcript isoforms or poorly annotated genes, suggesting the need for such 
focused studies. In contrast, most of the CNTs were found to be poorly conserved based on phastCons score pro-
files. Interestingly, we found a few of the CNTs as outliers in the box plot exhibiting extremely high conservation 
(Fig. 2c, CNTs, above third quartile), which met the median phastCons threshold of both known and CNTs, and 
hence are likely to be active but functionally uncharacterized for biological processes.
To understand whether particular functions and processes are over-represented as gene ontology (GO) cate-
gories for these novel transcripts, we performed functional enrichment analysis of the PNTs by using the anno-
tations of the corresponding mouse genes with which they overlap partially. To generate a high confident set 
of evolutionary conserved novel transcripts with annotated information, we filtered the PNTs with phastCons 
score > 0.8 and obtained a set of 3982 genes satisfying these criteria. We performed functional enrichment analy-
sis of these genes with corrected p-value (Bonferroni correction) threshold < 10−10 using ClueGO31. ClueGO is a 
Cytoscape plugin which enables the functional grouping of GO terms or gene sets to represent the enriched func-
tional themes as networks. Figure S2 shows the resulting network for GO biological processes. We found signifi-
cant clustering of genes into 26 thematic groups based on enriched GO terms using ClueGO (Table S3). Specific 
biological processes and associated modules are highlighted in Fig. 2d. We observed that ‘alternative mRNA splic-
ing via spliceosome’, ‘mRNA metabolism process’, ‘ubiquitin mediated proteolysis’, ‘nervous system development’, 
‘neurological system process’, ‘organelle organization’, ‘cell cycle’, ‘protein localization’ etc were over-represented 
in PNTs (Fig. 2d and Figure S2). For instance, we found group 19 (i.e. nervous system development) to be signif-
icantly enriched (adjusted p-value = 9.93e-32) with 841 genes i.e. ~30% of the genes (Table S3) annotated with 
neurogenesis, neuron differentiation and nervous system developmental processes. These observations clearly 
reveal the role of several poorly characterized transcripts associated with nervous system development, RNA 
metabolism, cell cycle, organelle and chromatin organization, regulation of anatomical structure morphogenesis 
and cell differentiation, during lens development.
Majority of the complete novel transcripts are widely expressed across developmental stages 
albeit exhibiting significantly lower expression, conservation and length compared to partially 
novel transcripts. We further investigated and compared the transcriptomes of the three groups of tran-
scripts across each developmental stage. We averaged the expression level of a transcript across biological repli-
cates in each developmental stage in order to compare the distribution of expression levels for known transcripts, 
PNTs and CNTs. We included the subset of transcripts in each class which were found to be expressed in all 
seven stages which resulted in 23121 known transcripts, 4531 PNTs and 4027 CNTs. The expression values were 
log-transformed and represented as box plot for each class across individual stages separately (Figure S3). We 
observed that, all three transcript classes exhibited significantly different expression profiles for each developmen-
tal stage (Wilcoxon rank sum test, p-value < 0.001, See Table S4), with known and PNTs exhibiting significantly 
higher expression compared to CNTs. In particular, our analysis also revealed that PNTs are highly expressed 
than known transcripts (Wilcoxon rank sum test, p-value < 0.001, See Table S4). These observations are similar to 
the conservation pattern of PNTs being higher than other transcript groups. These results indicate that PNTs are 
significantly more expressed than CNTs across all developmental stages and are often more expressed than even 
annotated transcripts suggesting that these PNTs are likely functional in lens development.
Although we observed that transcripts belonging to the CNT class were generally poorly conserved compared 
to the other two groups (Fig. 2c), nevertheless a small fraction (~8.6%) of CNTs exhibited high conservation 
with phastCons scores greater than 0.76. We considered these CNTs as highly conserved completely novel tran-
scripts because the median conservation score of known and partially novel transcripts was found to be 0.67 
and 0.76 respectively. In order to further interrogate the activity of these ~8.6% completely novel transcripts, we 
analyzed their expression profile across developmental stages. We further filtered them to obtain a set of CNTs 
with a phastCons score > 0.8 and expressed in at least one developmental stage, after excluding RNA-seq samples 
from E15.5 which originate from a different study in order to avoid any potential batch effect. We found a total 
of 647 CNTs (see Table S5) that exhibited varying levels of expression across developmental stages (Figure S4). 
Figure 3a shows a clustering snapshot of the distribution of these expression profiles across stages with expression 
levels of a transcript normalized by its maximum level across developmental stages (Materials and Methods, see 
Figure S4 for an extended heatmap). We analyzed the expression profiles of CNTs based on hierarchical clustering 
to identify representative panels of transcripts expressed in only one specific developmental stage (Fig. 3b) and 
in all developmental stages analyzed (Fig. 3c). These heatmap panels show the genomic co-ordinates as well as 
the novelty and phastCons scores associated with each CNT. We observed that ~10% of the CNTs (phastCons 
score > 0.8) were expressed in specific developmental stages as shown in Fig. 3b. In contrast, ~47% of the tran-
scripts were found to be expressed across all developmental stages, with a selected set of hierarchically clustered 
CNTs following this trend shown in Fig. 3c. This suggests that a small fraction of CNTs with uncharacterized 
function could be potentially regulating stage specific developmental processes while majority of the CNTs could 
have broader functional roles across stages albeit uncharacterized.
We also investigated the transcript structure of different transcript classes by comparing the number of exons 
and length distributions. We observed significant difference in the distribution of exonic composition for PNTs 
and known transcripts (p < 2.2e-16, Kolmogorov–Smirnov test), with majority of the PNTs being multiexonic 
(>3 exons). In particular, about 20% of the PNTs were found to have more than 20 exons and were enriched in 
genes associated with several processes including ‘microtubule cytoskeleton organization’, ‘cell cycle’, ‘nervous sys-
tem development’, ‘cell projection morphogenesis’, ‘embryo development’, ‘focal adhesion’ and ‘chromatin remode-
ling’. In contrast, we observed that ~90% of CNTs were single or bi-exonic with a small fraction of them exhibiting 
multiexonic structure as shown in Figure S5a. We also investigated the length for the three groups of transcripts 
and found significantly (p-value < 2.2e-16) varying distribution of lengths as shown in Figure S5b. We observed 
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that the known transcripts exhibited an expected distribution of transcript length as previously described32 with 
an abundance of transcripts having length between ~102 bp and ~104 bp. However, among the novel transcript 
groups; PNTs exhibited a distribution more similar to that of known transcripts when compared to CNTs. In par-
ticular, we observed that most PNTs had length ranging from 102–107 bp with abundance of transcripts having 
length in the range of 105–106 bp. In contrast, we found majority of the CNTs ranging in length from 102 to 105 bp 
dominated by relatively shorter length (100–1000 bp) transcripts. Indeed, studies from GENCODE consortium33 
observed that human long noncoding RNAs (lncRNAs) are typically encoded as single or biexonic transcripts 
with significantly lower exome lengths compared to annotated protein coding transcripts, suggesting that several 
of the CNTs detected in our study are likely to be noncoding RNAs.
We hypothesized that the varying exonic composition and transcript length distribution of CNTs could 
help further filter them in order to build a high confidence compendium of active CNTs for downstream anal-
ysis. We thus included transcript length as an additional parameter along with high conservation score to 
delineate probably functionally active 100% novel transcripts. We applied two sets of filters; a) 300 bp ≤ tran-
script length ≤ 10000 bp; phastCons score > 0.95; average expression > 5.0 TPM and expressed in at least four 
Figure 3. Completely novel transcripts (CNTs) with high conservation score (phastCons Score > 0.8), and 
expressed in atleast one developmental stage are shown across the panels. Expression profiles are normalized 
by the maximum expression level of a given transcript across stages and hierarchically clustered using Cluster 
3.0 and visualized as a heatmap using Java Treeview. Samples from E15.5 that came from a different study than 
the rest of the samples were excluded from this expression analysis in order to avoid the batch effect. Heat maps 
showing the expression profiles of (a) 647 completely novel (novelty score ≥ 70%) transcripts hierarchically 
clustered with representative transcript groups expressed (b) in only one specific developmental stage and (c) in 
all the developmental stages. Novelty score (NS) and phastCons score (PS) indices for transcripts are also shown 
in as an additional scale bar in each heat map. (d) RT-PCR analysis validates expression of two CNTs with a 
predicted ORF (MSTRG.8249.1 and MSTRG.18685.1) and two CNTs with no known ORF (MSTRG.17446.1 and 
MSTRG.21639.1) in E15.5, P0 and P10 lenses. Note that MSTRG.17446.1 is undetected in this analysis at stage 
E15.5. Hprt represents a loading control. Negative control is included for all CNTs tested where the RT-PCR 
reaction was performed using the same primers as for the CNTs but without any cDNA. Full-length gels are 
included in Supplementary Information file.
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developmental stages and b) 300 bp ≤ transcript length ≤ 10000 bp; phastCons score > 0.95; no expression thresh-
old; but expressed in at most two developmental stages to generate two sets of CNTs. Table 2 show a list of 25 
and 19 CNTs satisfying these two sets of filters respectively. To investigate if any of the highly conserved 25 CNTs 
can encode for potential functional protein coding sequences, we performed ORF prediction using an ad hoc 
Python script to detect both canonical and non-canonical start codons in six open reading frames. This analysis 
allowed us to confirm the presence of ORFs in 13 CNTs. Among these 13 ORFs, 8 of them were found to contain 
Gene ID Transcript ID Coordinates (mm10) Length (bp) Strand phastCons Score Novelty Score
MSTRG.10752 MSTRG.10752.1 16:91113662-91114155 493 . 0.997 100
MSTRG.11071 MSTRG.11071.1 17:16557283-16557630 347 . 0.997 100
MSTRG.11709 MSTRG.11709.2 17:39636629-39637143 514 − 0.997 100
MSTRG.13417 MSTRG.13417.2 19:17926989-17927998 1009 + 0.993 100
MSTRG.9039 MSTRG.9039.1 15:31655084-31655385 301 . 0.990 100
MSTRG.17446 MSTRG.17446.1 3:104752371-104752702 331 − 0.989 100
MSTRG.30048 MSTRG.30048.1 X:146176602-146177068 466 + 0.989 100
MSTRG.12849 MSTRG.12849.1 18:64611849-64612445 596 − 0.989 100
MSTRG.1816 MSTRG.1816.1 1:178299808-178300378 570 + 0.987 100
MSTRG.18663 MSTRG.18663.1 4:83421622-83422080 458 − 0.987 100
MSTRG.6455 MSTRG.6455.1 12:102866597-102867299 702 . 0.984 100
MSTRG.12840 MSTRG.12840.1 18:63543865-63545205 1340 + 0.981 100
MSTRG.21639 MSTRG.21639.1 5:127954976-127955377 401 . 0.978 100
MSTRG.8143 MSTRG.8143.1 14:33428605-33429024 419 . 0.973 100
MSTRG.13495 MSTRG.13495.1 19:25346816-25347223 407 . 0.973 100
MSTRG.15865 MSTRG.15865.1 2:157528311-157528617 306 . 0.970 100
MSTRG.20543 MSTRG.20543.1 5:46415104-46415426 322 + 0.970 100
MSTRG.6330 MSTRG.6330.1 12:86845755-86846203 448 . 0.970 100
MSTRG.8249 MSTRG.8249.1 14:48695580-48695978 398 . 0.969 100
MSTRG.7535 MSTRG.7535.1 13:91260953-91262729 1776 + 0.969 100
MSTRG.18684 MSTRG.18684.1 4:87103424-87105078 1654 + 0.967 100
MSTRG.18685 MSTRG.18685.1 4:87103426-87105078 1652 − 0.967 100
MSTRG.6715 MSTRG.6715.1 13:8289064-8289370 306 . 0.966 100
MSTRG.7905 MSTRG.7905.1 14:15949235-15949774 539 . 0.965 100
MSTRG.7913 MSTRG.7913.1 14:16451876-16452185 309 . 0.953 100
Gene ID Transcript ID Coordinates (mm10) Length (bp) Strand phastCons Score Novelty Score
MSTRG.16504 MSTRG.16504.1 3:36117033-36117334 301 . 1.000 100
MSTRG.18476 MSTRG.18476.1 4:53663579-53663885 306 . 0.993 100
MSTRG.12840 MSTRG.12840.2 18:63543888-63544690 802 + 0.989 100
MSTRG.444 MSTRG.444.1 1:52585218-52585601 383 . 0.988 100
MSTRG.7901 MSTRG.7901.1 14:14447656-14448019 363 . 0.982 100
MSTRG.25445 MSTRG.25445.1 7:127398616-127399037 421 . 0.980 100
MSTRG.3390 MSTRG.3390.1 10:129665538-129665871 333 . 0.975 100
MSTRG.6084 MSTRG.6084.1 12:72048695-72049032 337 . 0.975 100
MSTRG.10567 MSTRG.10567.1 16:53985023-53985331 308 . 0.973 100
MSTRG.10245 MSTRG.10245.1 16:23050282-23050873 591 . 0.973 100
MSTRG.6777 MSTRG.6777.2 13:15119006-15119437 431 + 0.970 100
MSTRG.26441 MSTRG.26441.1 8:72283729-72284163 434 . 0.969 100
MSTRG.10714 MSTRG.10714.1 16:88682165-88682703 538 . 0.966 100
MSTRG.25152 MSTRG.25152.1 7:107951379-107951776 397 . 0.963 100
MSTRG.14539 MSTRG.14539.1 2:34648981-34649511 530 − 0.956 100
MSTRG.6778 MSTRG.6778.2 13:15118406-15118934 528 + 0.956 100
MSTRG.13452 MSTRG.13452.1 19:23166931-23168119 1188 . 0.956 100
MSTRG.12890 MSTRG.12890.1 18:67920731-67921163 432 . 0.955 100
MSTRG.13017 MSTRG.13017.1 18:90311445-90311766 321 . 0.952 100
Table 2. High confidence list of 100% novel transcripts along with their genomic co-ordinates, length, 
strand and phastCons score. High confidence list of transcripts with transcript length (> 300 & < 10000 
bp), phastCons score > 0.95; and average expression > 5.0 TPM in atleast four developmental stages. High 
confidence list of transcripts unique to developmental stages with transcript length (>300 & < 10000), 
phastCons score > 0.95; expressed (no exp. threshold, as most of transcripts in this category are poorly 
expressed) in at most two developmental stages.
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Pfam domains according to HMMER34 (Table S6). We performed ORF prediction on 654 CNTs that are 100% 
novel and exhibited a phastCons score > 0.8. We observed that 202 of them encode for ORFs with 121 of them 
exhibiting at least one hit using HMMSCAN34 against Pfam, suggesting that at least 18% of the CNTs are likely to 
encode for functional domains (Table S7). Further, we validated four of the CNTs shown in Table 2 by RT-PCR 
in three different developmental stages of lens, among which two transcripts were predicted to encode for ORFs 
(Fig. 3d, Figure S6). We found that all the four completely novel transcripts were expressed in P0 and P10 stages. 
As predicted from our transcriptomic analysis, the MSTRG.17446.1 transcript was not detected at E15.5. These 
results further validate the stage-specific expression of CNTs shown in Fig. 3 and Table 2.
Splicing analysis reveals abundance of skipped exons and retained intron events across 
developmental stages. Alternative splicing is an important molecular mechanism which contributes 
to the transcriptomic diversity in higher eukaryotes35. Increasing evidence supports the role of splicing and 
post-transcriptional regulatory alterations in development11 and disease12, 36–38, in addition to their prominent 
role in generating multiple transcripts and protein isoforms in normal cells.
Since we observed significant differences in the distribution of novelty scores for novel transcripts between 
the embryonic and post-natal stages in mouse lens, we argued that alternative splicing could contribute to these 
differences. In addition to contributing to transcript isoforms, splicing events can also contribute to differen-
tial regulation of the gene products across developmental stages by controlling the abundance of the required 
isoform. Hence, we employed rMATS27, a framework for detecting splicing alterations from next generation 
RNA-sequencing datasets, to investigate such key events for molecular diversity across developmental stages (see 
Materials and Methods). Table 3 shows the number of high confident Alternative Splicing (AS) events detected 
using rMATS pipeline (FDR < 0.01) across every pair of developmental stages with replicates. Table includes the 
number of detected AS events reported to be significant by rMATS, for the five types of events namely skipped 
exon (SE), alternative 5′ splice site (A5SS), alternative 3′ splice site (A3SS), mutually exclusive exons (MXE) and 
retained intron (RI). These results clearly indicate an abundance of SE and RI events compared to the other types 
during lens development. Tables S8 and S9 summarizes the highly significant (1% FDR) SE and RI events discov-
ered across developmental stages.
Skipped exon events are the most abundant splicing events during lens development and are 
associated with differentiation, development and cytoskeletal regulatory pathways. Skipped 
exons are one of the most prevalent alternative splicing events in higher eukaryotes39. In these events, the splicing 
machinery can ‘skip over’ an exon by splicing it, thereby masking its contribution in the final RNA or protein 
product. We obtained 418 significant (FDR < 1%) exon skipping events corresponding to 266 exons observed in 
399 transcripts from 213 genes across various developmental stages (Table S8).
We performed functional enrichment analysis of the genes associated with skipped exonic events identified 
at 1% FDR using ClueGO31 (Materials and Methods). Enrichment results from this analysis are summarized 
in Table S10. We found several significant (adjusted p-value < 2.05e-04) groups of functional processes to be 
enriched including ‘mRNA processing’, ‘microtubule-based process’, ‘splicing factor NOVA regulated synpatic 
proteins’, ‘regulation of intrinsic apoptotic signaling pathway’, ‘lens development in camera-type eye’, ‘protein 
polymerization’, ‘tight junction’, ‘positive regulation of developmental growth’ and ‘striated muscle cell differ-
entiation’ (Table S10, Fig. 4a). These observations indicate the prevalence of skipped exonic events in several 
differentiation and developmental processes via post-transcriptional regulation. For instance, we found 6 genes 
significantly (adjusted p-value = 8.30e-05) associated with the term ‘lens development in camera-type eye’. The 
genes that belong to this functional theme include Cdk4 (Cyclin-Dependent Kinase 4), Cryba1 (Crystallin, Beta 
A1), Lim2 (Lens Intrinsic Membrane Protein 2), Meis1 (Meis Homeobox 1), Pax6 (Paired Box 6), and Smarca4 
(SWI/SNF Related, Matrix Associated, Actin Dependent Regulator of Chromatin, Subfamily A, Member 4), 
which contributes to ~8% of genes annotated with lens developmental processes.
Paired Box 6 (Pax6) is a transcription factor encoded by 14 exonic gene Pax6. This gene has previously 
been documented as a key regulator for sensory developmental processes40, 41 and lens regeneration42. We 
found that a particular exon, ENSMUSE00001311933 (Pax6) was included in all developmental stages except 
P9 with high Percent Splicing Index (PSI) values ranging between 0.93 and 0.99. Similarly, we found that 
ENSMUSE00000736151 (Cyclin-Dependent Kinase 4, Cdk4) is differentially included in E18 (PSI value = 0.964) 
versus P0 (PSI value = 0.8025) (FDR < 1%) and ENSMUSE00000691476 (Crystallin, Beta A4, Cryba4) is included 
all developmental stages except P0 with high PSI values ranging between 0.97 and 0.99, suggesting its importance 
in lens development (FDR < 1%) (Table 3).
Several skipped exonic events during lens development could be verified by RT-PCR and 
Sanger sequencing. We validated the expression of alternate isoforms of Pax6 and Cdk4 by RT-PCR and 
Sanger sequencing across developmental stages. Both Pax6 and Cdk4 follow the predicted trend (Table 3, Fig. 4b, 
Figures S7 and S8). For example, the ENSMUSE00001311933 exon of Pax6 is expressed at stages E15.5 and P0, 
while its expression is undetected at P10. Cdk4 exon ENSMUSE00000736151 is expressed at all three stages, 
E15.5, P0 and P10. Further, we validated skipped exonic events detected in four other genes (Banf1, Cryaa, Eif4g2, 
Rbm5) that have been detected at an FDR < 5% (Fig. 4b, Figure S7 and Table S8). Additional validation of these 
splicing events in P0 lens using Sanger sequencing independently confirmed our findings (Figure S8, Materials 
and Methods). Mutations in Cryaa have been previously shown to cause cataracts in humans and mice43, 44. Eif4g2 
and Rbm5 encode for RNA binding proteins and Banf1 encodes a DNA binding protein. While the function of 
these genes has not been characterized in the lens, they exhibit high expression in the lens tissue. Interestingly, 
another Rbm family protein, Rbm24, is expressed highly in vertebrate lens development45 and its deficiency 
in Zebrafish causes microphthalmia46. All five genes have alternatively spliced isoforms that are differentially 
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expressed across lens developmental stages, as predicted by splicing analysis (Table S10). For example, the 
ENSMUSE00000145472 exon of Banf1 is skipped at P10. Further, the ENSMUSE00000352893 exon of Cryaa 
is not highly expressed at any of the lens developmental stages tested, suggesting no potential function of the 
ENSMUST00000019192 transcript during late embryonic and early postnatal stages of mouse lens development. 
The isoform of Eif4g2 containing exon ENSMUSE00000203223 is expressed in all developmental stages, while 
the alternate isoform without the exon is not as highly expressed. Rbm5 has a distinct expression pattern during 
lens development. While the Rbm5 isoform including the ENSMUSE00001225318 exon is expressed at all stages, 

































SE 7 52 40 55 55 120 75 123 87 10 9 14 3 5 0
MXE 3 6 18 8 12 6 16 4 10 14 2 3 10 14 0
RI 62 46 25 26 37 73 29 31 34 6 2 9 0 1 2
A5SS 1 9 0 4 0 7 0 2 0 1 1 2 0 0 0
A3SS 3 4 3 3 3 12 5 7 5 1 2 0 1 0 1
Exon Skipping Events
Exon ID Coordinates (mm10) strand Transcript ID Gene Name E15 E18 P0 P3 P6 P9
ENSMUSE00000334942 19:57051130-57051234 − ENSMUST00000111559 Ablim1 NA 0.13 0.61 0.729 0.66 0.612
ENSMUSE00000668725 3:148849766-148849804 − ENSMUST00000197567 Adgrl2 0.202 0.24 0.61 NA 0.57 0.611
ENSMUSE00001324776 1:82891460-82891507 + ENSMUST00000190052 Agfg1 0.232 0.18 0.41 0.532 0.48 0.489
ENSMUSE00001039657 18:6057517-6057591 − ENSMUST00000182066 Arhgap12 0.289 0.32 0.82 NA NA NA
ENSMUSE00000700987 2:10056770-10056806 − ENSMUST00000114897 Atp5c1 0.822 0.76 0.55 0.55 0.62 0.574
ENSMUSE00000230008 18:32426224-32426352 + ENSMUST00000091967 Bin1 NA 0.68 0.18 NA NA NA
ENSMUSE00000217920 9:70004306-70004341 + ENSMUST00000034754 Bnip2 NA 0.5 0.9 0.806 NA 0.845
ENSMUSE00000736151 10:127064202-127064453 + ENSMUST00000133115 Cdk4 0.959 0.96 0.8 NA NA NA
ENSMUSE00000691476 5:112251747-112251797 − ENSMUST00000112385 Cryba4 0.974 0.98 NA 0.994 0.99 0.99
ENSMUSE00000311733 14:47726471-47726554 + ENSMUST00000022391 Ktn1 NA 0.24 0.5 0.476 NA 0.517
ENSMUSE00000440236 6:93680789-93680877 − ENSMUST00000204347 Magi1 0.118 0.09 NA NA 0.48 0.655
ENSMUSE00000667965 7:143518850-143518885 − ENSMUST00000072727 Nap1l4 0.477 0.42 0.29 0.228 0.25 0.245
ENSMUSE00001311933 2:105695306-105695456 + ENSMUST00000111082 Pax6 0.995 1 0.94 0.993 1 NA
ENSMUSE00000317905 15:93452117-93452173 + ENSMUST00000068457 Pphln1 0.151 0.07 0.57 0.356 0.5 0.639
ENSMUSE00000635082 9:86790056-86790139 − ENSMUST00000074468 Snap91 NA 0.85 0.27 0.248 0.2 NA
ENSMUSE00001196118 11:80393084-80393176 + ENSMUST00000123726 Zfp207 0.368 NA 0.67 NA 0.61 0.593
Intron Retention Events
Exon ID Coordinates (mm10) strand Transcript ID Gene Name E15 E18 P0 P3 P6 P9
ENSMUSE00000784872 3:103174340-103177419 + ENSMUST00000136937 Bcas2 0.039 0.0685 0.026 0.035 0.0225 0.031
ENSMUSE00000787504 11:101295534-101296316 − ENSMUST00000139997 Becn1 NA 0.1185 0.0635 0.062 0.051 0.044
ENSMUSE00000643467 2:91013238-91019497 + ENSMUST00000111452 Celf1 0.3755 0.709 0.612 0.8395 0.8565 0.846
ENSMUSE00001342001 1:165338188-165340023 − ENSMUST00000193353 Dcaf6 0.082 0.1555 0.0585 0.0635 0.052 0.0535
ENSMUSE00000842895 11:106782469-106784018 − ENSMUST00000133426 Ddx5 0.1375 0.1835 0.2265 0.3185 0.302 0.3625
ENSMUSE00000492954 3:95628541-95632102 + ENSMUST00000037983 Ensa 0.458 0.6615 0.4515 0.4335 0.4195 NA
ENSMUSE00001357022 3:152213977-152215630 + ENSMUST00000196062 Fubp1 0.0095 0.0535 0.058 0.0585 0.032 0.0515
ENSMUSE00000857219 1:161038225-161038539 + ENSMUST00000160516 Gas5 0.2265 0.289 0.0485 0.068 0.1195 0.099
ENSMUSE00001326780 7:31134414-31135739 − ENSMUST00000188032 Gramd1a 0.4465 0.7265 0.28 0.4175 0.319 0.307
ENSMUSE00000765273 11:50379468-50379964 + ENSMUST00000134230 Hnrnph1 0.093 NA 0.2775 0.1575 0.181 0.165
ENSMUSE00000756514 X:95947770-95950446 − ENSMUST00000126605 Las1l 0.0135 0.034 0.0545 0.041 0.043 0.0575
ENSMUSE00000764755 X:94537676-94538065 − ENSMUST00000153386 Maged1 0.064 0.1 0.0455 0.0525 0.045 0.0545
ENSMUSE00000777868 5:21743379-21746090 + ENSMUST00000125693 Pmpcb 0.0105 0.026 0.0865 0.033 0.0485 0.0665
ENSMUSE00000740654 X:8143848-8144679 − ENSMUST00000141925 Rbm3 0.0675 0.0985 0.0195 0.0405 0.044 0.0695
ENSMUSE00001332031 1:55014483-55016490 − ENSMUST00000187500 Sf3b1 0.1365 0.178 0.2265 0.264 0.284 0.282
Table 3. Identification of alternative splicing events using rMATS (replicate Multivariate Analysis of Transcript 
Splicing)27. Summary of the number of high confident Alternative Splicing (AS) events detected using rMATS 
pipeline (FDR <0.01) across developmental stages with replicates. Selected high confident exon skipping 
and intron retention events detected using rMATS pipeline (FDR <0.01) across developmental stages with 
replicates. Values across stages correspond to PSI values of the exons. Abbreviations used in the table stand for 
the following types of splicing events and definitions: SE- Skipped Exon, MXE- Mutually Exclusive Exon, RI- 
Retained Intron, A5SS- Alternative 5′ Splice Site, A3SS- Alternative 3′ Splice Site, PSI- Percent Spliced Index, 
FDR- False Discovery Rate.
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function for the ENSMUSE00001225318 exon at early perinatal stages. Together, the RT-PCR validation analysis 
suggests that alternatively spliced isoforms of genes expressed in the lens are also differentially expressed at differ-
ent developmental stages. This indicates that certain isoforms of genes function specifically during embryonic or 
postnatal development, indicating the significant contribution of post-transcriptional regulation to the functional 
diversity of the isoforms.
Genes associated with retained intronic events are enriched for developmental check point, 
cellular response to stress and RNA-splicing regulators. Retained intron (RI) is an important but less 
characterized AS mechanism. It causes retention of intronic region that may or may not also include some exonic 
regions during splicing (Fig. 5a). It is commonly suggested that, most of the transcripts exhibiting RI, could open 
a new targeting motif for small interfering RNA (siRNA) at RI loci, thus are degraded by nonsense-mediated 
decay47. However, recent studies indicate that intron-retaining mRNAs are likely to have a more conserved role 
in development and numerous diseases48. Our splicing analysis indicated that retained intron events are the sec-
ond most abundant alternative splicing events after skipped exon events (Table 3). We obtained 193 significant 
(FDR < 1%) intron retention events corresponding to 178 exons observed in 192 transcripts from 168 genes 
across various developmental stages (Table S9, Table 3).
Functional enrichment analysis of the genes which exhibited retained intronic events at 1% FDR threshold 
clearly revealed an enrichment for genes annotated with significant groups (p-value < 2.25e-04) such as ‘RNA 
splicing’, ‘M Phase’, ‘cellular responses to stress’, ‘autodegradation of Cdh1 by Cdh1:APC/C’, ‘regulation of RNA 
splicing’, ‘snRNP assembly’, ‘response to epidermal growth factor’ and ‘mitophagy’ suggesting that the genes 
whose regulation is controlled by intron retention appear to be associated with developmental check points 
or stress related (Fig. 5b and Table S11). For instance, we found several genes (Anapc2, Anapc5, Cdk4, Ehmt2, 
Ensa, H3f3b, Id1, Mcm7, Ncapg, Nup35, Pole, Ppp1cc, Psmc4, Psmd11, Psmd4, Rps27a, Tpr and Trp53) associated 
with cell cycle [M-Phase], which were found to be exhibiting retained introns in various developmental stages 
(Table S11). Similarly, we found genes associated with ‘autodegradation of Cdh1 by Cdh1: APC/C’ to be signif-
icantly enriched (p-value = 1.87e-07) with 15 genes (Anapc2, Anapc5, Atg4b, Becn1, Cdk4, Ehmt2, H3f3b, Id1, 
Map1lc3b, Psmc4, Psmd11, Psmd4, Rps27a, Trp53, Wipi2) contributing to 6% of the genes associated with Cdh1 
mediated proteolysis/ degradation of mitotic proteins. Cdh1 (epithelial cadherin) is an important protein which 
controls the mitotic arrest with G1-phase elongation in neurogenesis49.
Celf1 (also known as CUG triplet repeat, RNA binding protein 1) is a well characterized RNA binding protein 
belonging to the CUG-BP family. CUG-BP family is known for protein members, which control the embry-
onically lethal abnormal vision via potential involvement in developmentally regulated alternative splicing50. 
Figure 4. Functional analysis and validation of the high confident exon skipping events discovered across lens 
developmental states. (a) Functional enrichment analysis of genes associated with high confidence (FDR 1%) 
skipped exon events identified using rMATS27 pipeline in atleast one pairwise comparison of developmental 
stages. For each biological process per group (color coded), the % genes per GO term with number of query 
genes (** in red) in the analysis is shown in histogram. This shows the functional grouping of the GO-terms 
based on GO hierarchy using the Cytoscape67-ClueGO31 plugin. Significant clusters (p < 1e-2), color coded 
by group based on enriched GO-biological processes generated from ClueGO analysis with size of the nodes 
indicating level of significant association of genes per GO-term. (b) Experimental validation by RT-PCR 
analysis of a selected set of high confident skipped exonic events reveals that selected mRNA isoforms with 
skipped events are more abundant during embryonic and perinatal stages. The schematic of the expected 
products are shown next to the gene. For validation, primers (arrows) were designed on the exons (black box) 
flanking the alternatively spliced exon (grey box). For all the genes, band with higher molecular weight is the 
isoform including the alternatively spliced exon and band with lower molecular weight is the isoform with the 
skipped exon. Hprt represents a loading control. Negative control is included for all isoforms tested where the 
RT-PCR reaction was performed using the same primers as for the isoforms but without any cDNA. Full-length 
gels are included in Fig. S6.
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Celf1 is a highly conserved RNA binding protein, involved in alternative splicing, polyadenylation, mRNA sta-
bility, and translation processes51. Additionally, Celf1 was documented to potentially regulate the genes involved 
in embryonic heart muscle development51, 52 with some support for the role of these family members in lens 
development53. In our analysis, we found that the last exon - ENSMUSE00000643467 (Celf1) exhibited retained 
intronic event with high PSI values in post-natal developmental stages compared to embryonic stages, with a very 
low abundance in E15 as shown in Fig. 5c. In addition to Celf1, several other RBPs were found to exhibit intron 
Figure 5. Functional analysis of the genes associated with high confident retained intron events across lens 
developmental stages. (a) Overview of intron retention mechanism (b) Functional enrichment analysis of 
genes associated with significant (FDR 1%) intron retention events identified using rMATS27 in atleast one 
pair of developmental stages compared. For each biological process per group (color coded), the % genes 
per GO term with number of query genes (** in red) in the analysis was shown in histogram. This shows the 
functional grouping of the GO-terms based on GO hierarchy was represented as Clustered GO-network using 
the Cytoscape67-ClueGO31 plugin. Significant clusters (p < 1e-2), color coded by group based on enriched 
GO-biological processes generated from ClueGO analysis with size of the nodes indicating level of significant 
association of genes per GO-term. (c) Bubble plot showing the alterations in the inclusion levels of a retained 
intron for Celf1 across various developmental stages. Each bubble shows the Percent Spliced Index (PSI) of the 
retained intron indicating an increase in the inclusion level from embryonic to post-natal stages.
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retention events supporting the notion that RBPs can be regulated post-transcriptionally by non-sense mediated 
mRNA decay of the unproductive splicing isoforms which might harbor stop codons54. These observations sug-
gest a stage dependent regulation of RBP’s transcript levels by auto-regulation at post transcriptional level, to fine 
tune the downstream post-transcriptional regulatory networks in lens development.
Eye Splicer: an interactive web-based genome browser for visualizing alternative splicing 
events across lens developmental stages. To facilitate easy access to the discovered splicing events 
across lens developmental stages, we have set up an interactive web-based genome browser, Eye Splicer (accessible 
via http://www.iupui.edu/~sysbio/eye-splicer/) powered by Biodalliance JavaScript library that enables visualiz-
ing skipped exon and retained intron events across developmental stages as tracks. After we collected inclusion 
levels from rMATS, we converted these into BED formatted text files, which were further converted into BigBed 
files to make them suitable for loading into Eye Splicer (see Materials and Methods). Figure S9 shows a screenshot 
of Eye Splicer showing a skipped exon event for ENSMUSE00001072738 exon of Srsf2 (serine/arginine-rich splic-
ing factor 2) gene. In this figure, which is manually edited to fit it in a small area, the change from E15 to P9 can 
be seen as the height of the bars corresponding to the PSI values scaled from 0 to 1. These clickable bars for each 
developmental stage provide a pop up a table summarizing the corresponding inclusion levels for the particular 
event type. Srsf2 belongs to a family of pre-mRNA splicing factors, and constitute the spliceosome complex with 
documented role during embryonic development55. Our results indicate that the inclusion of this exon is increas-
ing towards the later developmental stages. While in E15 PSI value of the skipped exon is 0.0535, it becomes 0.245 
by increasing 4.5 times.
Discussion
In this study, we investigated the transcriptomic alterations and splicing events during lens formation (i.e. across 
different developmental stages; E15, E15.5, E18, P0, P3, P6 and P9), and constructed a molecular portrait of 
known and novel transcript isoforms in the mouse lens. Although samples from the developmental time point 
E15.5 originated from a different study and read length distribution compared to the rest of the datasets, com-
parison of the annotated gene expression profiles in the mouse genome between E15.5 and E15 stages revealed a 
significant correlation (Pearson R = 0.86, p < 2.2e-16), suggestive of significant similarity in the expression pro-
files of developmentally close time points, irrespective of the source and sequencing platform. In contrast, expres-
sion profiles from E18 and post-natal stages exhibited lower correlation with respect to E15.5 dataset, further 
confirming the quality and robustness of expression profiles to delineate the developmental stages. Although, 
increasing number of studies using RNA-sequencing protocols are able to generate a wild type control as part of 
their research projects leading to stage-specific developmental transcriptomes56–58, several issues need to be con-
sidered before employing them in large-scale meta-analysis studies, which can significantly improve the quality 
and number of high confidence predictions. For instance, several of these publicly available datasets are generated 
with single replicates, provide separate transcriptomes of epithelial and fiber cells as opposed to whole lens, are 
generated with differing read lengths and arise from different labs. Hence, future efforts to integrate the datasets 
should account for sample heterogeneity by normalizing the samples before expression quantification or modi-
fications should be adopted in splicing prediction software to account for variable sequencing fragment lengths 
across datasets.
Classification of ~25% of the total transcripts defined as novel transcripts, into partially and completely 
novel transcript types (PNTs and CNTs) based on their extent of overlap with current annotations, allowed us 
to uncover the properties of these transcript sub-types. We found that the extent of novelty of the transcripts 
decreased significantly in post-natal lens stages compared to embryonic stages, suggesting the presence of several 
uncharacterized novel transcript forms expressed during early lens development. PNTs were found to exhibit 
significantly higher conservation as well as expression levels compared to both completely novel and known tran-
scripts, across the developmental stages studied here. Functional analysis of PNTs suggested the prominent role 
of several processes such as neural system development, structural morphogenesis, protein localization, cell divi-
sion and differentiation, important for lens development. Notably, majority of the CNTs were widely expressed 
across developmental stages albeit exhibiting significantly lower expression, conservation and length compared 
to partially novel transcripts. Nevertheless, ORF prediction on a subset of ~600 CNTs which are conserved across 
all the studied species indicated protein coding ability for at least 30% of these novel transcripts. We confirm the 
expression of several of these CNTs across lens developmental stages. Functional analysis of the genes exhibiting 
the most abundant alternative splicing events, namely skipped exon and retained intron events, revealed the 
enrichment of mRNA processing, apoptotic signaling pathways, protein polymerization, cell development and 
differentiation for the former and the enrichment of cell cycle processes, stress and splicing regulation for the later 
type of events. We found several genes such as Banf1, Cdk4, Cryaa, Eif4g2, Pax6 and Rbm5 that are associated 
with lens development, to exhibit skipped exonic events. We have validated the expression of different isoforms 
as well as novel genes in developing mouse lens by qRT-PCR. Further, we have developed a splicing browser ‘Eye 
Splicer’ to access and view developmentally altered splicing events in mouse lens. Together, this in-depth analysis 
provides a high-resolution architecture of the mouse lens transcriptome and provides a one-stop portal for fur-
thering the understanding of splicing alterations during lens development.
Materials and Methods
To obtain a comprehensive understanding of the transcriptome and splicing alterations across various stages 
of lens development, we collected multiple publicly available RNA-seq datasets corresponding to the raw RNA 
sequence reads of mouse lens from different developmental stages (Table 1). These datasets were aligned to the 
mouse reference genome, quantified for expression levels of known and novel transcripts as well as to investigate 
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splicing alterations as illustrated in the workflow (Fig. 1). In the following sections, each of the major steps 
employed in processing and analysis are described in further detail.
Datasets employed and quality filtering of RNA-seq samples. We collected the raw RNA sequence 
reads of different developmental stages (E15, E15.5, E18, P0, P3, P6 and P9 each with its biological replicate) of 
mouse lens from Gene Expression Omnibus (GEO)59 and European Nucleotide Archive (ENA)60. Table 1 shows 
the relevant source of the RNA-seq dataset along with several metrics resulting from the alignment of the reads 
to the reference genome. Briefly, we downloaded the single end datasets in FASTQ format using the SRA Toolkit 
(fastq-dump command), and the paired end datasets were directly downloaded from ENA. We ensured the qual-
ity of the aligned sequence reads to a minimum quality score of 20 for each sample using FASTX-Toolkit (http://
hannonlab.cshl.edu/fastx_toolkit/index.html).
Sequence alignment of quality filtered RNA-Seq reads using HISAT. HISAT25 (Hierarchical 
Indexing for Spliced Alignment of Transcripts) is a highly efficient alignment tool for aligning short reads from 
RNA sequencing experiments onto reference genome. We used HISAT with default parameters and setting the 
number of processors to 32, for rapidly aligning the quality filtered RNA sequence reads collected from different 
sources (See Table 1) against mouse reference genome mm10 annotation files. SAM (Sequence Alignment/Map) 
files obtained as outputs from HISAT were post processed using SAMtools (version 0.1.19)61, 62 for converting 
SAM to BAM (Binary Alignment/Map) followed by sorting the output BAM files. The sorted binary alignment 
files (sorted-BAM) obtained after post-processing were employed for further data processing i.e. quantification 
of expression levels of transcripts and splicing analysis.
Transcript identification and quantification from the aligned RNA-seq datasets. We used 
StringTie (version 1.2.1)26 for identification and quantification of transcripts from the aligned RNA-Seq reads. 
StringTie is novel network flow algorithm based on fast and highly efficient assembler, to quantitate the tran-
scripts of each genomic locus considering all possible multiple splice events. In addition to annotated transcripts, 
it can also provide the information of possible novel transcripts in each sample. Transcript level expression data 
quantified using StringTie were stored in GTF (Gene Transfer Format) providing expression levels for both 
known as well as novel transcripts against mouse reference genome (mm10-Mus_musculus.GRCm38.84.gtf). All 
the GTFs previously obtained for each sample were grouped and provided as an input for stringtie “merge” mode 
along with mouse reference genome (mm10-Mus_musculus.GRCm38.84.gtf). The merged GTF thus obtained 
was then utilized as reference annotation file in re-running StringTie with the sorted-BAM for the correspond-
ing samples. As a result, we obtained a matrix of expression levels for 90689 transcripts (68166 annotated and 
22523 novel transcripts) in the mouse genome. Known transcripts are defined as the transcripts whose genomic 
co-ordinates and annotations completely overlapped with those reported in Ensembl database63 for the mouse 
genome. In contrast, novel transcripts were defined as the transcripts that were exclusively predicted by StringTie 
and hence could overlap partially with already annotated exonic regions in the mouse genome. A quantification 
matrix was generated for lens transcriptome with respect to different developmental stages extracting the TPM 
(transcripts per million) values from StringTie outputs. This matrix was utilized for downstream analysis.
Defining and investigating the novel transcripts across developmental stages. We calculated the 
proportion of known and novel transcripts for each RNA-seq sample with an expression threshold of TPM > 1.0 
and averaged the values for corresponding replicates from each developmental stage. The obtained proportions 
were represented as a bar graph for each developmental stage. Similarly, we calculated the proportion of known 
and novel transcripts with varying expression thresholds (TPM > 0.5, >2 and >5) and represented as bar graphs 
to study the reproducibility of our observed trends.
To investigate the discovered novel transcripts for their extent of novelty with respect to the known transcript 
architectures documented in the mouse reference genome mm10, we mapped the length of the discovered tran-
script to annotated reference transcript coordinates and calculated a novelty score for each novel transcript by 








×Novelty Score 1 length overlapping region
full length of novel transcript
100
We examined the distribution of novelty score of novel transcripts in each developmental stage and repre-
sented it as a density plot. We performed K–S (Kolmogorov–Smirnov) test to investigate for statistically sig-
nificant differences in the novelty score distributions between any pair of developmental stages. Based on prior 
calculations and distribution of novelty scores, we categorized the novel transcripts into two groups; partially 
novel transcripts (PNTs, novelty score < 70%) and completely novel transcripts (CNTs, novelty score ≥ 70%). We 
analyzed the expression levels of transcripts across all stages for each transcript group - known, partially anno-
tated novel and completely novel transcripts and performed Wilcoxon rank sum test to study the distribution of 
expression levels between transcript groups for each developmental stage separately. These results were repre-
sented as box plots in supplementary material.
RT-PCR analysis of CNTs. To validate the expression levels of novel transcripts discovered from RNA-Seq 
analysis, total RNA was extracted using a RNeasy Mini kit (Qiagen Inc, Valencia, CA) from microdissected 
C57Bl/6 mouse lenses at three stages, namely, embryonic day (E) 15.5, and post-natal day (P)0 and P10. Each of 
the three biological replicates at E15.5 comprised of six lenses, and at P0 and P10 comprised of two lenses. RNA 
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was treated with RNase free DNase (Qiagen Inc #79254, Valencia, CA). cDNA was synthesized from 200 ng of 
total RNA, representing three biological replicates at each developmental stage using Bio-Rad iScriptTM cDNA 
Synthesis Kit (Bio-Rad Laboratories, Hercules, CA), and was used as a template in PCR analysis. Primers were 
designed for the exonic regions of four CNTs (Table S12). The PCR products were run on 1% agarose gel. Presence 
of specific bands at the expected size were indicative of transcript expression in the lens.
Phylogenetic conservation of mouse lens transcriptome. Although some reports indicate that 
mouse lens is likely to have a diverse transcriptome, the evolutionary significance of the transcriptome is poorly 
understood. Hence to address this, we investigated the evolutionary conservation of the identified transcripts. 
Multiple sequence alignment of genomic loci across several genomes provides a comprehensive snapshot 
of the evolutionary conservation, which can act as a proxy for functional preservation of a selected region64. 
For instance, protein coding genomic loci were documented to be highly conserved across the genome than 
non-functional genomic loci65. We applied this technique to conjecture and identify novel transcripts which 
could be functionality active across large phylogenetic distances. We downloaded the phastCons scores66 from 
the UCSC Genome Browser for the complete mouse genome. PhastCons score employed in this study provides 
an estimate of the individual nucleotide level conservation, calculated based on multiple sequence alignment of 
46 vertebrate genomes with respect to mouse reference genome mm10. It ranges from 0–1 with higher the score 
higher is the conservation of the individual nucleotide across the genomes. For this study, we utilized the available 
nucleotide resolution conservation score data for mm10 and calculated the phastCons score for each exon of the 
novel transcripts by averaging the per-base scores and then computed a representative conservation score for each 
transcript as the mean phastCons score of the exons representing the novel transcript. Final scores were analyzed 
for known (annotated) transcripts, PNTs and CNTs to compare their relative extents of conservation.
Since Gene Ontology (GO) based functional enrichment analysis can provide important clues about the 
functions and molecular processes predominantly associated with novel transcripts, we analyzed the Partially 
Novel Transcripts (PNTs) that shared majority (>70%) of their genomic region with known/annotated tran-
script containing genes to understand the likely functions associated with them. This involved filtering the PNTs 
with phastCons score (>0.8) to first identify highly conserved transcripts and using the resulting set of genes 
associated with these PNTs for downstream functional analysis. Functional enrichment analysis was performed 
with p-value threshold < 10−10 for collected genes using Cytoscape67-ClueGO31 plugin and was represented as a 
clustered GO network. Significant clustering of genes, color coded by annotation group, based on enriched GO 
biological processes were highlighted in these representations.
Transcripts belonging to the completely novel class share less than 30% of their genomic region with known 
transcripts. We hypothesized that completely novel transcripts with high conservation and expressed in at least 
one developmental stage could be active with uncharacterized function. Hence, we filtered the transcripts based 
on phastCons score (>0.8) and analyzed their expression pattern. Expression profiles normalized by their max-
imum expression level across stages for these highly conserved completely novel transcripts were hierarchically 
clustered using Cluster 3.068 and visualized as a heatmap using Java Treeview69. Representative hierarchically 
clustered panels of transcripts expressed in only one specific developmental stage and in all developmental stages 
were shown separately. Novelty Score (NS) and phastCons Score (PS) indices for transcripts were shown as an 
additional scale bar in each heatmap.
We also investigated the distribution of the number of exons and length of the transcripts for known, par-
tially novel and completely novel transcripts. We performed K–S (Kolmogorov-Smirnov) test to evaluate whether 
length distributions of transcripts significantly differ. Likewise, exon counts were also compared for these three 
categories of transcripts.
In order to identify high confident completely novel transcripts for potential experimental validation, we 
applied three simultaneous filters namely phastCons score, expression and transcript length. Briefly, these robust 
filters comprised of novelty score set to 100% and (a) 300 ≤ transcript length ≤ 10000; phastCons score > 0.95; 
and average transcript expression (across all developmental stage) > 5.0 TPM in at least four developmental stages 
to generate novel transcript predictions broadly expressed across developmental stages and (b) 300 ≤ transcript 
length ≤ 10000; phastCons score > 0.95; exhibits expression in at most two developmental stages to generate 
novel transcript predictions specifically expressed in particular developmental stages. Resulting sets of broadly 
expressed, highly conserved and 100% novel transcripts were selected for experimental validation and discussed 
in the results section.
Analysis of differential alternative splicing. RNA-Seq data provides an opportunity to detect differen-
tial alternative splicing events across conditions. Since we have two replicates of RNA-seq for each developmental 
stage of mouse lens tissue resulting from the same sequencing platform, we applied rMATS (replicate Multivariate 
Analysis of Transcript Splicing)27 to identify differential alternative splicing (AS) events. rMATS provides a com-
putational framework to identify all possible splicing events which are altered between two samples, by inspecting 
the status of exons/introns as they are included or excluded resulting from alternative splicing. We used sorted 
BAM (Binary Alignment/Map) files, obtained from aligning the raw RNA-seq datasets against the mouse refer-
ence genome using HISAT as discussed above, as input to rMATS by pairing with their corresponding replicates 
from each developmental stage. This allowed us to compare each pair of developmental stages for alterations in 
various splicing events. Since rMATS requires all input datasets to have the same read length, we excluded the 
dataset from E15.5 which had a different read length compared to others. Also, we have provided the GFF 
(General Feature Format) file downloaded from Ensembl (version 82, September 2015)70 as input to rMATS and 
have used the default thresholds for remaining options. Briefly, rMATS enabled us to analyze the inclusion/exclu-
sion of target exons/introns contributing to different types of alternative splicing events, namely skipped exon 
(SE), alternative 5′ splice site (A5SS), alternative 3′ splice site (A3SS), mutually exclusive exons (MXE) and 
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retained intron (RI), across any pair of developmental stages with replicates. An AS event is quantified based on 
the difference in the level of inclusion of an exon which is defined as the splice index or Percentage Splicing Index 
( scoreψ ) between two samples or conditions and ranges between 0 and 1. PSI represents the inclusion/exclusion 
of an exon for a transcript isoform considering all alternate possible isoforms. Reads aligning to the alternative 
exon or to its junctions with adjacent constitutive exons provide support for the inclusion isoform, whereas reads 
aligning to the junction between the adjacent constitutive exons support the exclusion isoform; the relative read 
density of these two sets forms the standard estimate of ψ. Significant differences in the values of ψ for an exon, 
between a pair of conditions compared to a null distribution indicate its differential abundance. We ran rMATS 
for all pairs of six developmental stages (E15, E18, P0, P3, P6 and P9) and generated a summary table with the 
number of different alternative splicing events that were detected below 1% FDR threshold (Table 3). Since 
skipped exon and retained intron events were the most abundant, we collected these events from raw rMATS 
outputs specifically those which are supported by reads that span splicing junctions and reads on target below 1% 
FDR. Functional enrichment analysis of genes belonging to these splicing events was performed using ClueGO31.
Experimental validation of the skipped exons. To confirm splicing events during lens development, 
we selected genes based on their potential relevance to lens biology and which were predicted with less than 
5% FDR in our splicing analysis. For alternative splicing analysis, primers (listed in Table S12) were designed 
on exons flanking the alternatively spliced exon (skipped exon) on either side. Total RNA from E15.5, P0 and 
P10 C57Bl/6 mouse lens was collected as described above. RNA was treated with RNase free DNase (Qiagen Inc 
#79254, Valencia, CA). 200ng of lens total RNA was used as template for cDNA synthesis using in vitro reverse 
transcription kit as described earlier and cDNA was used as a template for PCR reactions. The different splice iso-
forms were identified based on size differences of PCR products separated by 1% agarose gel electrophoresis. We 
further analyzed the PCR products obtained using RNA from P0 lens by Sanger sequencing. The different splice 
isoform DNA bands from the P0 lens samples were excised from the gel and subjected to DNA purification using 
Wizard® SV Gel and PCR Clean-Up System (Promega #A9281, Madison, WI). DNA isolated from specific splice 
isoforms was sequenced by Sanger sequencing method.
Development of a splicing browser for studying splicing alterations across developmental 
stages. The abundant AS events that were detected in this study namely skipped exons and retained introns, 
were made available for visualization via Eye Splicer (http://www.iupui.edu/~sysbio/eye-splicer/), an interactive 
web-based splicing browser for studying splicing alterations in mouse lens. Eye Splicer is built using the JavaScript 
library from Biodalliance (http://www.biodalliance.org). As Biodalliance requires BED (Browser Extensible Data) 
or BigBed formatted input files, we preprocessed these tables into BED formatted text files and generated the cor-
responding BigBed files, which are the compressed version of BED files and hence suitable for the web using the 
UCSC tools71. Eye Splicer has a simple interface with the lists of genes that have exons alternatively spliced below 
1% FDR for skipped exons and retained introns, shown on the left menu and an interactive genome browser on 
the right which allows the visualization of the exons of interest upon selection from the gene lists or upon search 
using its text field that supports coordinate based search or gene name/Ensembl ID based search. Any viewable 
section of the splicing browser, can be exported using the Export button as SVG (scalable vector graphics). Eye 
Splicer is freely available on http://www.iupui.edu/~sysbio/eye-splicer/ and can be accessed without any login 
requirement.
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